Clay Park betamethasone cream recall
Syosset Labs was incorrectly identified in FDA's Dec. 11 "Enforcement Report" as one of the distributors of Clay Park's betamethasone dispropionate .05% cream that is the subject of a Class II recall ("The Pink Sheet" Dec. 16, T&G-12). "Syosset has never received any betamethasone dipropionate cream from Clay Park," the firm notes.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth